BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32721504)

  • 1. Erythropoietin is a major regulator of thrombopoiesis in thrombopoietin-dependent and -independent contexts.
    Hacein-Bey-Abina S; Estienne M; Bessoles S; Echchakir H; Pederzoli-Ribeil M; Chiron A; Aldaz-Carroll L; Leducq V; Zhang Y; Souyri M; Louache F; Abina AM
    Exp Hematol; 2020 Aug; 88():15-27. PubMed ID: 32721504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of platelet lifespan in the presence and absence of thrombopoietin signaling.
    Lebois M; Dowling MR; Gangatirkar P; Hodgkin PD; Kile BT; Alexander WS; Josefsson EC
    J Thromb Haemost; 2016 Sep; 14(9):1882-7. PubMed ID: 27344013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation.
    Ng AP; Kauppi M; Metcalf D; Hyland CD; Josefsson EC; Lebois M; Zhang JG; Baldwin TM; Di Rago L; Hilton DJ; Alexander WS
    Proc Natl Acad Sci U S A; 2014 Apr; 111(16):5884-9. PubMed ID: 24711413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokinetics.
    Li J; Xia Y; Kuter DJ
    Br J Haematol; 1999 Aug; 106(2):345-56. PubMed ID: 10460590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
    Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
    Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin.
    Bunting S; Widmer R; Lipari T; Rangell L; Steinmetz H; Carver-Moore K; Moore MW; Keller GA; de Sauvage FJ
    Blood; 1997 Nov; 90(9):3423-9. PubMed ID: 9345025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human adipose tissue-derived stromal cells can differentiate into megakaryocytes and platelets by secreting endogenous thrombopoietin.
    Ono-Uruga Y; Tozawa K; Horiuchi T; Murata M; Okamoto S; Ikeda Y; Suda T; Matsubara Y
    J Thromb Haemost; 2016 Jun; 14(6):1285-97. PubMed ID: 26990635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of focal adhesion kinase (FAK) in megakaryopoiesis and platelet function: studies using a megakaryocyte lineage specific FAK knockout.
    Hitchcock IS; Fox NE; Prévost N; Sear K; Shattil SJ; Kaushansky K
    Blood; 2008 Jan; 111(2):596-604. PubMed ID: 17925492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombocytopenia in c-mpl-deficient mice.
    Gurney AL; Carver-Moore K; de Sauvage FJ; Moore MW
    Science; 1994 Sep; 265(5177):1445-7. PubMed ID: 8073287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Milestones in understanding platelet production: a historical overview.
    Kuter DJ
    Br J Haematol; 2014 Apr; 165(2):248-58. PubMed ID: 24528208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombopoietin and the c-Mpl receptor: insights from gene targeting.
    Alexander WS
    Int J Biochem Cell Biol; 1999 Oct; 31(10):1027-35. PubMed ID: 10582337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of erythroid differentiation and induction of megakaryocytic differentiation by thrombopoietin are regulated by two different mechanisms in TPO-dependent UT-7/c-mpl and TF-1/c-mpl cell lines.
    Goncalves F; Lacout C; Féger F; Cohen-Solal K; Guichard J; Cramer E; Vainchenker W; Duménil D
    Leukemia; 1998 Sep; 12(9):1355-66. PubMed ID: 9737683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretion expression and activity assay of a novel fusion protein of thrombopoietin and interleukin-6 in Pichia pastoris.
    Zhiyi H; Wenshan L; Wenze Z; Ning D; Chi Z; Kenan Y; Ping W; Qianqian W; Qing Z
    J Biochem; 2007 Jul; 142(1):17-24. PubMed ID: 17517790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Congenital amegakaryocytic thrombocytopenia (CAMT) - a defect of the thrombopoietin receptor c-Mpl].
    Germeshausen M; Schulze H; Gaudig A; Krukemeier S; Strauss G; Welte K; Ballmaier M
    Klin Padiatr; 2001; 213(4):155-61. PubMed ID: 11528548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental Stage-Specific Manifestations of Absent TPO/c-MPL Signalling in Newborn Mice.
    Lorenz V; Ramsey H; Liu ZJ; Italiano J; Hoffmeister K; Bihorel S; Mager D; Hu Z; Slayton WB; Kile BT; Sola-Visner M; Ferrer-Marin F
    Thromb Haemost; 2017 Dec; 117(12):2322-2333. PubMed ID: 29212120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Megakaryopoiesis: regulation of platelet production by thrombopoietin].
    Vainchenker W; Besancenot R; Favale F
    Bull Acad Natl Med; 2013 Feb; 197(2):395-406. PubMed ID: 24919369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting a thrombopoietin-independent strategy in the discovery of a novel inducer of megakaryocytopoiesis, DMAG, for the treatment of thrombocytopenia.
    Wang L; Liu S; Luo J; Mo Q; Ran M; Zhang T; Li X; Zou W; Mei Q; Chen J; Yang J; Zeng J; Huang F; Wu A; Zhang C; Wu J
    Haematologica; 2023 May; 108(5):1394-1411. PubMed ID: 36546424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombopoietin in vitro and in vivo.
    Alexander WS; Begley CG
    Cytokines Cell Mol Ther; 1998 Mar; 4(1):25-34. PubMed ID: 9557214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a novel megakaryopoiesis enhancer, ingenol, promoting thrombopoiesis through PI3K-Akt signaling independent of thrombopoietin.
    Wang L; Zhang T; Liu S; Mo Q; Jiang N; Chen Q; Yang J; Han YW; Chen JP; Huang FH; Li H; Zhou J; Luo JS; Wu JM
    Pharmacol Res; 2022 Mar; 177():106096. PubMed ID: 35077844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombopoietin (TPO) induces thrombocytic colony formation of kidney cells synergistically with kit ligand A and a non-secretory TPO variant exists in common carp.
    Katakura F; Sugie Y; Hayashi K; Nishiya K; Miyamae J; Okano M; Nakanishi T; Moritomo T
    Dev Comp Immunol; 2018 Jul; 84():327-336. PubMed ID: 29522790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.